Form 4: Quest Diagnostics SVP Acquires Shares and Options in Recent Transaction

Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, reports acquisition of shares and stock options.

Summary

• Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership.
• On February 12, 2025, Plewman acquired 2,042 shares of common stock.
• These shares were acquired at $0, likely representing an award of restricted stock units.
• Plewman also acquired 7,833 non-qualified stock options with an exercise price of $165.30, exercisable beginning February 12, 2026, and expiring February 12, 2035.
• Following the reported transactions, Plewman beneficially owns 18,402 shares of common stock and 7,833 derivative securities.
• The amount of shares includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing detailing executive stock transactions, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of shares and options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the stock options suggests a multi-year commitment from the executive.

Industry Context

Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders. This filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like Quest Diagnostics.
• Comparable companies such as Laboratory Corporation of America (LH) also utilize similar equity-based compensation strategies to incentivize and retain key personnel.
• The vesting schedules and exercise prices of these options are generally aligned with industry norms and designed to reward long-term value creation.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates

Keywords

Quest Diagnostics, DGX, Form 4, Beneficial Ownership, Patrick Plewman, Stock Options, Restricted Stock Units, SVP Diagnostic Services